Novel motif:67: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:52, 9 September 2013
name: | motif67_GNTAAC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0002544 | chronic inflammatory response | 1.282735e-9 |
GO:0016476 | regulation of embryonic cell shape | 4.722616e-9 |
GO:0010038 | response to metal ion | 5.372973e-8 |
GO:0071842 | cellular component organization at cellular level | 1.579434e-7 |
GO:0016043 | cellular component organization | 2.020590e-7 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 3.823374e-7 |
GO:0071840 | cellular component organization or biogenesis | 4.849073e-7 |
GO:0042221 | response to chemical stimulus | 5.144895e-7 |
GO:0051276 | chromosome organization | 5.505559e-7 |
GO:0051258 | protein polymerization | 6.227989e-7 |
GO:0042135 | neurotransmitter catabolic process | 9.309803e-7 |
GO:0006104 | succinyl-CoA metabolic process | 9.720722e-7 |
GO:0031129 | inductive cell-cell signaling | 1.523825e-6 |
GO:0070827 | chromatin maintenance | 1.906622e-6 |
GO:0035945 | mitochondrial ncRNA surveillance | 1.906622e-6 |
GO:0035946 | mitochondrial mRNA surveillance | 1.906622e-6 |
GO:0010033 | response to organic substance | 2.570744e-6 |
GO:0030299 | intestinal cholesterol absorption | 2.779431e-6 |
GO:0048619 | embryonic hindgut morphogenesis | 3.635822e-6 |
GO:0006996 | organelle organization | 3.636359e-6 |
GO:0009068 | aspartate family amino acid catabolic process | 6.485813e-6 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 6.515816e-6 |
GO:0032514 | positive regulation of protein phosphatase type 2B activity | 7.011167e-6 |
GO:0045666 | positive regulation of neuron differentiation | 8.284885e-6 |
GO:0007049 | cell cycle | 8.541846e-6 |
GO:0051592 | response to calcium ion | 9.504806e-6 |
GO:0030030 | cell projection organization | 9.919263e-6 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 1.105528e-5 |
GO:0008152 | metabolic process | 1.116634e-5 |
GO:0034622 | cellular macromolecular complex assembly | 1.218671e-5 |
GO:0050916 | sensory perception of sweet taste | 1.410697e-5 |
GO:0002526 | acute inflammatory response | 1.468294e-5 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.613001e-5 |
GO:0032512 | regulation of protein phosphatase type 2B activity | 1.693436e-5 |
GO:0009066 | aspartate family amino acid metabolic process | 1.701412e-5 |
GO:0015949 | nucleobase-containing small molecule interconversion | 1.816743e-5 |
GO:0044237 | cellular metabolic process | 1.819137e-5 |
GO:0043030 | regulation of macrophage activation | 1.944270e-5 |
GO:0032990 | cell part morphogenesis | 1.976522e-5 |
GO:0043623 | cellular protein complex assembly | 2.097520e-5 |
GO:0006325 | chromatin organization | 2.121677e-5 |
GO:0034621 | cellular macromolecular complex subunit organization | 2.285155e-5 |
GO:0010940 | positive regulation of necrotic cell death | 2.362316e-5 |
GO:0048858 | cell projection morphogenesis | 2.712751e-5 |
GO:0033120 | positive regulation of RNA splicing | 2.732446e-5 |
GO:0009310 | amine catabolic process | 2.771594e-5 |
GO:0043503 | skeletal muscle fiber adaptation | 2.784372e-5 |
GO:0032026 | response to magnesium ion | 2.860017e-5 |
GO:0042060 | wound healing | 3.183477e-5 |
GO:0009611 | response to wounding | 3.212022e-5 |
GO:0008219 | cell death | 3.214837e-5 |
GO:0008228 | opsonization | 3.348431e-5 |
GO:0006950 | response to stress | 3.616525e-5 |
GO:0006781 | succinyl-CoA pathway | 3.665679e-5 |
GO:0034197 | triglyceride transport | 3.820043e-5 |
GO:0016265 | death | 4.000798e-5 |
GO:0032890 | regulation of organic acid transport | 4.066739e-5 |
GO:0051642 | centrosome localization | 4.227173e-5 |
GO:0007599 | hemostasis | 4.278972e-5 |
GO:0030240 | skeletal muscle thin filament assembly | 4.500252e-5 |
GO:0044238 | primary metabolic process | 4.546309e-5 |
GO:0070106 | interleukin-27-mediated signaling pathway | 4.721244e-5 |
GO:0048015 | phosphatidylinositol-mediated signaling | 4.907864e-5 |
GO:0060004 | reflex | 4.997249e-5 |
GO:0032989 | cellular component morphogenesis | 5.141812e-5 |
GO:0034763 | negative regulation of transmembrane transport | 5.171433e-5 |
GO:0007596 | blood coagulation | 5.367799e-5 |
GO:0032891 | negative regulation of organic acid transport | 5.384393e-5 |
GO:0002023 | reduction of food intake in response to dietary excess | 5.604380e-5 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 6.482148e-5 |
GO:0006542 | glutamine biosynthetic process | 6.554453e-5 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 6.648035e-5 |
GO:0050896 | response to stimulus | 7.053772e-5 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 7.860020e-5 |
GO:0061034 | olfactory bulb mitral cell layer development | 7.967039e-5 |
GO:0051320 | S phase | 8.790155e-5 |
GO:0043933 | macromolecular complex subunit organization | 9.085375e-5 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 9.382639e-5 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 9.382639e-5 |
GO:0071353 | cellular response to interleukin-4 | 9.390799e-5 |
GO:0000902 | cell morphogenesis | 9.625175e-5 |
GO:0090274 | positive regulation of somatostatin secretion | 9.770811e-5 |
GO:0045023 | G0 to G1 transition | 9.770811e-5 |
GO:0031334 | positive regulation of protein complex assembly | 1.082716e-4 |
GO:0060556 | regulation of vitamin D biosynthetic process | 1.103313e-4 |
GO:0044241 | lipid digestion | 1.154279e-4 |
GO:0045214 | sarcomere organization | 1.155191e-4 |
GO:0035871 | protein K11-linked deubiquitination | 1.194373e-4 |
GO:0060005 | vestibular reflex | 1.199409e-4 |
GO:0010288 | response to lead ion | 1.206008e-4 |
GO:0009987 | cellular process | 1.230960e-4 |
GO:0030538 | embryonic genitalia morphogenesis | 1.231644e-4 |
GO:0055096 | low-density lipoprotein particle mediated signaling | 1.266311e-4 |
GO:0071526 | semaphorin-plexin signaling pathway | 1.281511e-4 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 1.291769e-4 |
GO:0030827 | negative regulation of cGMP biosynthetic process | 1.356060e-4 |
GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 1.452117e-4 |
GO:0006467 | protein thiol-disulfide exchange | 1.452117e-4 |
GO:0042420 | dopamine catabolic process | 1.463128e-4 |
GO:0010939 | regulation of necrotic cell death | 1.533383e-4 |
GO:0022402 | cell cycle process | 1.534232e-4 |
GO:0010722 | regulation of ferrochelatase activity | 1.580252e-4 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 1.667998e-4 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 1.667998e-4 |
GO:0012501 | programmed cell death | 1.690512e-4 |
GO:0006241 | CTP biosynthetic process | 1.694788e-4 |
GO:0010883 | regulation of lipid storage | 1.876410e-4 |
GO:0060191 | regulation of lipase activity | 1.924684e-4 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 2.036753e-4 |
GO:2000659 | regulation of interleukin-1-mediated signaling pathway | 2.040100e-4 |
GO:0030534 | adult behavior | 2.087869e-4 |
GO:0050878 | regulation of body fluid levels | 2.132447e-4 |
GO:0010922 | positive regulation of phosphatase activity | 2.157113e-4 |
GO:0007442 | hindgut morphogenesis | 2.280374e-4 |
GO:0006554 | lysine catabolic process | 2.282276e-4 |
GO:0072093 | metanephric renal vesicle formation | 2.306329e-4 |
GO:0048263 | determination of dorsal identity | 2.330099e-4 |
GO:0022002 | negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway | 2.330099e-4 |
GO:2000191 | regulation of fatty acid transport | 2.364715e-4 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 2.445148e-4 |
GO:0000084 | S phase of mitotic cell cycle | 2.501207e-4 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 2.527017e-4 |
GO:0030321 | transepithelial chloride transport | 2.535580e-4 |
GO:0006927 | transformed cell apoptosis | 2.535580e-4 |
GO:0001778 | plasma membrane repair | 2.591738e-4 |
GO:0031123 | RNA 3'-end processing | 2.817705e-4 |
GO:0019932 | second-messenger-mediated signaling | 2.978393e-4 |
GO:0043277 | apoptotic cell clearance | 3.161597e-4 |
GO:0023057 | negative regulation of signaling | 3.396401e-4 |
GO:0046683 | response to organophosphorus | 3.415809e-4 |
GO:0010648 | negative regulation of cell communication | 3.505903e-4 |
GO:0065003 | macromolecular complex assembly | 3.519717e-4 |
GO:0031175 | neuron projection development | 3.668623e-4 |
GO:0050917 | sensory perception of umami taste | 3.771102e-4 |
GO:0009968 | negative regulation of signal transduction | 3.790519e-4 |
GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter | 3.801316e-4 |
GO:0033345 | asparagine catabolic process via L-aspartate | 3.801316e-4 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 3.991145e-4 |
GO:0042424 | catecholamine catabolic process | 4.040639e-4 |
GO:0048666 | neuron development | 4.079709e-4 |
GO:0016568 | chromatin modification | 4.142878e-4 |
GO:0009895 | negative regulation of catabolic process | 4.327789e-4 |
GO:0006925 | inflammatory cell apoptosis | 4.501979e-4 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 4.651130e-4 |
GO:0035456 | response to interferon-beta | 4.700634e-4 |
GO:0050892 | intestinal absorption | 4.904765e-4 |
GO:0043032 | positive regulation of macrophage activation | 4.945382e-4 |
GO:0006119 | oxidative phosphorylation | 5.090038e-4 |
GO:0016570 | histone modification | 5.148892e-4 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 5.214031e-4 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 5.215757e-4 |
GO:0048585 | negative regulation of response to stimulus | 5.238277e-4 |
GO:0006915 | apoptosis | 5.426062e-4 |
GO:0071822 | protein complex subunit organization | 5.654041e-4 |
GO:0050885 | neuromuscular process controlling balance | 5.814385e-4 |
GO:0051726 | regulation of cell cycle | 5.986306e-4 |
GO:0006214 | thymidine catabolic process | 6.001672e-4 |
GO:0072092 | ureteric bud invasion | 6.041445e-4 |
GO:0006464 | protein modification process | 6.101213e-4 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 6.234845e-4 |
GO:0031124 | mRNA 3'-end processing | 6.621419e-4 |
GO:0001937 | negative regulation of endothelial cell proliferation | 6.657713e-4 |
GO:0071803 | positive regulation of podosome assembly | 6.880854e-4 |
GO:0010390 | histone monoubiquitination | 7.041688e-4 |
GO:0042133 | neurotransmitter metabolic process | 7.059670e-4 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 7.285786e-4 |
GO:0046685 | response to arsenic-containing substance | 7.305135e-4 |
GO:0048812 | neuron projection morphogenesis | 7.345793e-4 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 7.368994e-4 |
GO:0043067 | regulation of programmed cell death | 7.416979e-4 |
GO:0010921 | regulation of phosphatase activity | 7.440115e-4 |
GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein | 7.610337e-4 |
GO:0060662 | salivary gland cavitation | 7.653842e-4 |
GO:0080135 | regulation of cellular response to stress | 7.723956e-4 |
GO:0060008 | Sertoli cell differentiation | 8.014189e-4 |
GO:0007010 | cytoskeleton organization | 8.470527e-4 |
GO:0003008 | system process | 8.673884e-4 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 8.755265e-4 |
GO:0010738 | regulation of protein kinase A signaling cascade | 8.801684e-4 |
GO:0010941 | regulation of cell death | 9.175199e-4 |
GO:0070848 | response to growth factor stimulus | 9.178472e-4 |
GO:0018293 | protein-FAD linkage | 9.348013e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 9.348013e-4 |
GO:0006953 | acute-phase response | 9.405978e-4 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 9.562836e-4 |
GO:0007603 | phototransduction, visible light | 9.562836e-4 |
GO:0002819 | regulation of adaptive immune response | 9.574057e-4 |
GO:0032461 | positive regulation of protein oligomerization | 9.738099e-4 |
GO:0060445 | branching involved in salivary gland morphogenesis | 9.823929e-4 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 9.857477e-4 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 9.978277e-4 |
GO:0021881 | Wnt receptor signaling pathway involved in forebrain neuron fate commitment | 1.003048e-3 |
GO:0007611 | learning or memory | 1.010264e-3 |
GO:0006212 | uracil catabolic process | 1.014280e-3 |
GO:0006210 | thymine catabolic process | 1.014280e-3 |
GO:0042981 | regulation of apoptosis | 1.017459e-3 |
GO:0065008 | regulation of biological quality | 1.032114e-3 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.046936e-3 |
GO:0051893 | regulation of focal adhesion assembly | 1.081419e-3 |
GO:0006564 | L-serine biosynthetic process | 1.096612e-3 |
GO:0044267 | cellular protein metabolic process | 1.098756e-3 |
GO:0001936 | regulation of endothelial cell proliferation | 1.102199e-3 |
GO:0016569 | covalent chromatin modification | 1.118901e-3 |
GO:0022008 | neurogenesis | 1.121500e-3 |
GO:0070670 | response to interleukin-4 | 1.129782e-3 |
GO:0008210 | estrogen metabolic process | 1.144195e-3 |
GO:0031639 | plasminogen activation | 1.146476e-3 |
GO:0050830 | defense response to Gram-positive bacterium | 1.163478e-3 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 1.170084e-3 |
GO:0016226 | iron-sulfur cluster assembly | 1.198487e-3 |
GO:0006447 | regulation of translational initiation by iron | 1.200273e-3 |
GO:0010743 | regulation of macrophage derived foam cell differentiation | 1.219529e-3 |
GO:0071956 | cellular component maintenance at cellular level | 1.274425e-3 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.284451e-3 |
GO:0021915 | neural tube development | 1.313251e-3 |
GO:0002821 | positive regulation of adaptive immune response | 1.357829e-3 |
GO:0019538 | protein metabolic process | 1.370982e-3 |
GO:0043241 | protein complex disassembly | 1.429308e-3 |
GO:0043501 | skeletal muscle adaptation | 1.438336e-3 |
GO:0019264 | glycine biosynthetic process from serine | 1.451130e-3 |
GO:0002576 | platelet degranulation | 1.460351e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.474924e-3 |
GO:0035921 | desmosome disassembly | 1.505368e-3 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 1.505368e-3 |
GO:0050905 | neuromuscular process | 1.508585e-3 |
GO:0021781 | glial cell fate commitment | 1.520165e-3 |
GO:0007610 | behavior | 1.540294e-3 |
GO:0043412 | macromolecule modification | 1.552537e-3 |
GO:0000117 | regulation of transcription involved in G2/M-phase of mitotic cell cycle | 1.559512e-3 |
GO:0010755 | regulation of plasminogen activation | 1.605121e-3 |
GO:0032236 | positive regulation of calcium ion transport via store-operated calcium channel activity | 1.636784e-3 |
GO:0031104 | dendrite regeneration | 1.636950e-3 |
GO:0016571 | histone methylation | 1.664542e-3 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.672413e-3 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.677199e-3 |
GO:0048262 | determination of dorsal/ventral asymmetry | 1.696774e-3 |
GO:0010646 | regulation of cell communication | 1.713373e-3 |
GO:0031579 | membrane raft organization | 1.722870e-3 |
GO:0035458 | cellular response to interferon-beta | 1.728136e-3 |
GO:0045663 | positive regulation of myoblast differentiation | 1.734020e-3 |
GO:0015918 | sterol transport | 1.808166e-3 |
GO:2000334 | positive regulation of blood microparticle formation | 1.815443e-3 |
GO:0019859 | thymine metabolic process | 1.815443e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 1.823239e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.848894e-3 |
GO:0060677 | ureteric bud elongation | 1.891903e-3 |
GO:0044070 | regulation of anion transport | 1.906399e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 1.917898e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 1.936307e-3 |
GO:0071363 | cellular response to growth factor stimulus | 1.941319e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 2.000405e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 2.000405e-3 |
GO:0019230 | proprioception | 2.032332e-3 |
GO:0048523 | negative regulation of cellular process | 2.037374e-3 |
GO:2000121 | regulation of removal of superoxide radicals | 2.038179e-3 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 2.072561e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 2.078412e-3 |
GO:0006563 | L-serine metabolic process | 2.103237e-3 |
GO:0006642 | triglyceride mobilization | 2.108595e-3 |
GO:0006491 | N-glycan processing | 2.108595e-3 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2.115701e-3 |
GO:0055114 | oxidation-reduction process | 2.117709e-3 |
GO:0006513 | protein monoubiquitination | 2.149730e-3 |
GO:0007597 | blood coagulation, intrinsic pathway | 2.213004e-3 |
GO:0060009 | Sertoli cell development | 2.229437e-3 |
GO:0022411 | cellular component disassembly | 2.251026e-3 |
GO:0006693 | prostaglandin metabolic process | 2.279744e-3 |
GO:0042758 | long-chain fatty acid catabolic process | 2.281288e-3 |
GO:0042413 | carnitine catabolic process | 2.281288e-3 |
GO:0007409 | axonogenesis | 2.283204e-3 |
GO:0048769 | sarcomerogenesis | 2.291300e-3 |
GO:0072376 | protein activation cascade | 2.339980e-3 |
GO:0043313 | regulation of neutrophil degranulation | 2.345536e-3 |
GO:0051895 | negative regulation of focal adhesion assembly | 2.386720e-3 |
GO:0032423 | regulation of mismatch repair | 2.395211e-3 |
GO:0032608 | interferon-beta production | 2.402487e-3 |
GO:0010825 | positive regulation of centrosome duplication | 2.402487e-3 |
GO:0030036 | actin cytoskeleton organization | 2.426681e-3 |
GO:0014866 | skeletal myofibril assembly | 2.437278e-3 |
GO:0009064 | glutamine family amino acid metabolic process | 2.470882e-3 |
GO:0030029 | actin filament-based process | 2.471181e-3 |
GO:0016310 | phosphorylation | 2.486500e-3 |
GO:0071844 | cellular component assembly at cellular level | 2.497770e-3 |
GO:0072033 | renal vesicle formation | 2.513125e-3 |
GO:0045870 | positive regulation of retroviral genome replication | 2.517575e-3 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 2.527669e-3 |
GO:0048468 | cell development | 2.537813e-3 |
GO:0019220 | regulation of phosphate metabolic process | 2.565139e-3 |
GO:0043170 | macromolecule metabolic process | 2.578008e-3 |
GO:0032680 | regulation of tumor necrosis factor production | 2.599509e-3 |
GO:0035771 | interleukin-4-mediated signaling pathway | 2.607142e-3 |
GO:0010839 | negative regulation of keratinocyte proliferation | 2.607142e-3 |
GO:0014050 | negative regulation of glutamate secretion | 2.632263e-3 |
GO:0042176 | regulation of protein catabolic process | 2.633795e-3 |
GO:0010824 | regulation of centrosome duplication | 2.663370e-3 |
GO:0034441 | plasma lipoprotein particle oxidation | 2.664659e-3 |
GO:0001544 | initiation of primordial ovarian follicle growth | 2.664659e-3 |
GO:0009063 | cellular amino acid catabolic process | 2.673904e-3 |
GO:0070103 | regulation of interleukin-6-mediated signaling pathway | 2.736503e-3 |
GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway | 2.753424e-3 |
GO:0006145 | purine base catabolic process | 2.753424e-3 |
GO:0043652 | engulfment of apoptotic cell | 2.780203e-3 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.780203e-3 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 2.780203e-3 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 2.780203e-3 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 2.780203e-3 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.787715e-3 |
GO:0051660 | establishment of centrosome localization | 2.965026e-3 |
GO:0021540 | corpus callosum morphogenesis | 2.965026e-3 |
GO:0050877 | neurological system process | 2.967181e-3 |
GO:0022607 | cellular component assembly | 2.998309e-3 |
GO:0050890 | cognition | 3.002204e-3 |
GO:0032369 | negative regulation of lipid transport | 3.011065e-3 |
GO:0050806 | positive regulation of synaptic transmission | 3.022831e-3 |
GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine | 3.037345e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 3.044875e-3 |
GO:0042417 | dopamine metabolic process | 3.091704e-3 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.134884e-3 |
GO:0007050 | cell cycle arrest | 3.213242e-3 |
GO:0001556 | oocyte maturation | 3.247277e-3 |
GO:0007007 | inner mitochondrial membrane organization | 3.275464e-3 |
GO:0051481 | reduction of cytosolic calcium ion concentration | 3.298428e-3 |
GO:0046104 | thymidine metabolic process | 3.343101e-3 |
GO:0008628 | induction of apoptosis by hormones | 3.343101e-3 |
GO:0071103 | DNA conformation change | 3.498325e-3 |
GO:0009088 | threonine biosynthetic process | 3.509432e-3 |
GO:2000345 | regulation of hepatocyte proliferation | 3.537970e-3 |
GO:0010035 | response to inorganic substance | 3.576630e-3 |
GO:0006687 | glycosphingolipid metabolic process | 3.587229e-3 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 3.650701e-3 |
GO:0009615 | response to virus | 3.766113e-3 |
GO:0007435 | salivary gland morphogenesis | 3.831271e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.881140e-3 |
GO:0001573 | ganglioside metabolic process | 3.889142e-3 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 3.941048e-3 |
GO:0048699 | generation of neurons | 3.942636e-3 |
GO:0006689 | ganglioside catabolic process | 3.953603e-3 |
GO:0010757 | negative regulation of plasminogen activation | 3.970528e-3 |
GO:0071447 | cellular response to hydroperoxide | 4.024367e-3 |
GO:0021797 | forebrain anterior/posterior pattern specification | 4.054391e-3 |
GO:0071025 | RNA surveillance | 4.093353e-3 |
GO:0010226 | response to lithium ion | 4.178415e-3 |
GO:0060271 | cilium morphogenesis | 4.217696e-3 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 4.273069e-3 |
GO:0034498 | early endosome to Golgi transport | 4.346712e-3 |
GO:0015939 | pantothenate metabolic process | 4.412012e-3 |
GO:0044085 | cellular component biogenesis | 4.427462e-3 |
GO:0016192 | vesicle-mediated transport | 4.442030e-3 |
GO:0000904 | cell morphogenesis involved in differentiation | 4.465651e-3 |
GO:0032606 | type I interferon production | 4.525116e-3 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 4.527374e-3 |
GO:0030301 | cholesterol transport | 4.538901e-3 |
GO:0006887 | exocytosis | 4.558892e-3 |
GO:0051135 | positive regulation of NK T cell activation | 4.640365e-3 |
GO:0071636 | positive regulation of transforming growth factor beta production | 4.666773e-3 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 4.671805e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 4.671805e-3 |
GO:0009060 | aerobic respiration | 4.693213e-3 |
GO:0051325 | interphase | 4.706352e-3 |
GO:0060291 | long-term synaptic potentiation | 4.772178e-3 |
GO:0007015 | actin filament organization | 4.801167e-3 |
GO:0015911 | plasma membrane long-chain fatty acid transport | 4.805839e-3 |
GO:0035583 | negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta | 4.841312e-3 |
GO:0071675 | regulation of mononuclear cell migration | 4.944728e-3 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 4.954897e-3 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 4.969932e-3 |
GO:0010888 | negative regulation of lipid storage | 4.972315e-3 |
GO:0010759 | positive regulation of macrophage chemotaxis | 5.044105e-3 |
GO:0061041 | regulation of wound healing | 5.064014e-3 |
GO:0042044 | fluid transport | 5.107678e-3 |
GO:0051179 | localization | 5.113547e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 5.127544e-3 |
GO:0048519 | negative regulation of biological process | 5.144543e-3 |
GO:0060548 | negative regulation of cell death | 5.150601e-3 |
GO:0032800 | receptor biosynthetic process | 5.174388e-3 |
GO:0070194 | synaptonemal complex disassembly | 5.176763e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 5.176763e-3 |
GO:0015886 | heme transport | 5.363044e-3 |
GO:0045597 | positive regulation of cell differentiation | 5.412832e-3 |
GO:0019934 | cGMP-mediated signaling | 5.518793e-3 |
GO:0070271 | protein complex biogenesis | 5.520107e-3 |
GO:0002437 | inflammatory response to antigenic stimulus | 5.560976e-3 |
GO:0032501 | multicellular organismal process | 5.633189e-3 |
GO:0021553 | olfactory nerve development | 5.644373e-3 |
GO:0090304 | nucleic acid metabolic process | 5.646863e-3 |
GO:0032464 | positive regulation of protein homooligomerization | 5.674281e-3 |
GO:0046322 | negative regulation of fatty acid oxidation | 5.696284e-3 |
GO:0009586 | rhodopsin mediated phototransduction | 5.760490e-3 |
GO:0031099 | regeneration | 5.820401e-3 |
GO:0035518 | histone H2A monoubiquitination | 5.850501e-3 |
GO:0070265 | necrotic cell death | 5.893529e-3 |
GO:0015855 | pyrimidine base transport | 5.893529e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 5.893529e-3 |
GO:0006461 | protein complex assembly | 5.933521e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 5.980342e-3 |
GO:0019254 | carnitine metabolic process, CoA-linked | 5.998672e-3 |
GO:0051568 | histone H3-K4 methylation | 6.060659e-3 |
GO:0032237 | activation of store-operated calcium channel activity | 6.092430e-3 |
GO:2000503 | positive regulation of natural killer cell chemotaxis | 6.115948e-3 |
GO:2000513 | positive regulation of granzyme A production | 6.115948e-3 |
GO:2000518 | negative regulation of T-helper 1 cell activation | 6.115948e-3 |
GO:2000538 | positive regulation of B cell chemotaxis | 6.115948e-3 |
GO:0071663 | positive regulation of granzyme B production | 6.115948e-3 |
GO:2000412 | positive regulation of thymocyte migration | 6.115948e-3 |
GO:0035740 | CD8-positive, alpha-beta T cell proliferation | 6.115948e-3 |
GO:0035739 | CD4-positive, alpha-beta T cell proliferation | 6.115948e-3 |
GO:0035744 | T-helper 1 cell cytokine production | 6.115948e-3 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 6.134839e-3 |
GO:0043031 | negative regulation of macrophage activation | 6.176990e-3 |
GO:0006398 | histone mRNA 3'-end processing | 6.176990e-3 |
GO:0045218 | zonula adherens maintenance | 6.197383e-3 |
GO:0097035 | regulation of membrane lipid distribution | 6.217684e-3 |
GO:0051917 | regulation of fibrinolysis | 6.217684e-3 |
GO:0042177 | negative regulation of protein catabolic process | 6.346005e-3 |
GO:0071310 | cellular response to organic substance | 6.373561e-3 |
GO:0010758 | regulation of macrophage chemotaxis | 6.394005e-3 |
GO:0047496 | vesicle transport along microtubule | 6.421503e-3 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 6.539118e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 6.539118e-3 |
GO:0015721 | bile acid and bile salt transport | 6.581888e-3 |
GO:0006958 | complement activation, classical pathway | 6.721610e-3 |
GO:0042489 | negative regulation of odontogenesis of dentine-containing tooth | 6.752511e-3 |
GO:0032959 | inositol trisphosphate biosynthetic process | 6.764335e-3 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 6.784076e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 6.793407e-3 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 6.809448e-3 |
GO:0032958 | inositol phosphate biosynthetic process | 6.861009e-3 |
GO:0030049 | muscle filament sliding | 6.901812e-3 |
GO:0007431 | salivary gland development | 6.987668e-3 |
GO:0010517 | regulation of phospholipase activity | 7.140682e-3 |
GO:0070683 | mitotic cell cycle G2/M transition decatenation checkpoint | 7.140866e-3 |
GO:0021984 | adenohypophysis development | 7.155497e-3 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 7.195241e-3 |
GO:0051707 | response to other organism | 7.274344e-3 |
GO:0006807 | nitrogen compound metabolic process | 7.308190e-3 |
GO:0016070 | RNA metabolic process | 7.334605e-3 |
GO:0030194 | positive regulation of blood coagulation | 7.383354e-3 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 7.440812e-3 |
GO:0016082 | synaptic vesicle priming | 7.453156e-3 |
GO:0001766 | membrane raft polarization | 7.453156e-3 |
GO:0002376 | immune system process | 7.489454e-3 |
GO:0001843 | neural tube closure | 7.518477e-3 |
GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 7.589102e-3 |
GO:0070294 | renal sodium ion absorption | 7.628792e-3 |
GO:0030157 | pancreatic juice secretion | 7.642904e-3 |
GO:0009584 | detection of visible light | 7.663680e-3 |
GO:0006796 | phosphate-containing compound metabolic process | 7.710751e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 7.773060e-3 |
GO:0035082 | axoneme assembly | 7.879206e-3 |
GO:0006265 | DNA topological change | 7.879206e-3 |
GO:0090291 | negative regulation of osteoclast proliferation | 7.901997e-3 |
GO:2000347 | positive regulation of hepatocyte proliferation | 7.901997e-3 |
GO:2000349 | negative regulation of CD40 signaling pathway | 7.901997e-3 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 7.901997e-3 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 7.901997e-3 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 7.901997e-3 |
GO:0072573 | tolerance induction to lipopolysaccharide | 7.901997e-3 |
GO:0031100 | organ regeneration | 7.970406e-3 |
GO:0071622 | regulation of granulocyte chemotaxis | 7.988967e-3 |
GO:0043069 | negative regulation of programmed cell death | 8.004226e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 8.027929e-3 |
GO:0035330 | regulation of hippo signaling cascade | 8.028424e-3 |
GO:0006266 | DNA ligation | 8.070481e-3 |
GO:0060216 | definitive hemopoiesis | 8.074661e-3 |
GO:0006629 | lipid metabolic process | 8.100420e-3 |
GO:0006833 | water transport | 8.112016e-3 |
GO:0006396 | RNA processing | 8.183043e-3 |
GO:0051318 | G1 phase | 8.332968e-3 |
GO:0030838 | positive regulation of actin filament polymerization | 8.363356e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 8.407152e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 8.414697e-3 |
GO:0042953 | lipoprotein transport | 8.430832e-3 |
GO:0021935 | cerebellar granule cell precursor tangential migration | 8.454185e-3 |
GO:0033151 | V(D)J recombination | 8.485596e-3 |
GO:0032006 | regulation of TOR signaling cascade | 8.554943e-3 |
GO:0009653 | anatomical structure morphogenesis | 8.560157e-3 |
GO:0030162 | regulation of proteolysis | 8.586292e-3 |
GO:0048566 | embryonic digestive tract development | 8.642603e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 8.712382e-3 |
GO:0060606 | tube closure | 8.757741e-3 |
GO:0001841 | neural tube formation | 8.840494e-3 |
GO:0001774 | microglial cell activation | 8.841722e-3 |
GO:0050908 | detection of light stimulus involved in visual perception | 8.867130e-3 |
GO:0050820 | positive regulation of coagulation | 8.874496e-3 |
GO:0007030 | Golgi organization | 8.883897e-3 |
GO:0060218 | hemopoietic stem cell differentiation | 8.909164e-3 |
GO:0032924 | activin receptor signaling pathway | 8.913478e-3 |
GO:0008202 | steroid metabolic process | 8.916124e-3 |
GO:0048853 | forebrain morphogenesis | 8.916126e-3 |
GO:0016567 | protein ubiquitination | 9.099798e-3 |
GO:0010815 | bradykinin catabolic process | 9.110299e-3 |
GO:0001696 | gastric acid secretion | 9.110299e-3 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 9.131767e-3 |
GO:0032411 | positive regulation of transporter activity | 9.134042e-3 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 9.212446e-3 |
GO:0007525 | somatic muscle development | 9.222318e-3 |
GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback | 9.222318e-3 |
GO:0006479 | protein methylation | 9.288813e-3 |
GO:0030168 | platelet activation | 9.310780e-3 |
GO:0010955 | negative regulation of protein processing | 9.338543e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050892 | intestinal absorption | 4.685122e-12 |
GO:0009410 | response to xenobiotic stimulus | 5.698804e-9 |
GO:0022600 | digestive system process | 4.660465e-8 |
GO:0060282 | positive regulation of oocyte development | 1.165781e-7 |
GO:0060281 | regulation of oocyte development | 1.165781e-7 |
GO:0032814 | regulation of natural killer cell activation | 2.022310e-7 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 2.552435e-7 |
GO:0032423 | regulation of mismatch repair | 5.461325e-7 |
GO:0006805 | xenobiotic metabolic process | 6.315976e-7 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 9.142123e-7 |
GO:0001914 | regulation of T cell mediated cytotoxicity | 1.091234e-6 |
GO:0032890 | regulation of organic acid transport | 1.100128e-6 |
GO:0006651 | diacylglycerol biosynthetic process | 1.107074e-6 |
GO:0002699 | positive regulation of immune effector process | 2.318281e-6 |
GO:0014050 | negative regulation of glutamate secretion | 2.557911e-6 |
GO:0034394 | protein localization at cell surface | 2.668794e-6 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 6.672993e-6 |
GO:0032816 | positive regulation of natural killer cell activation | 8.364515e-6 |
GO:0008210 | estrogen metabolic process | 9.217491e-6 |
GO:0051707 | response to other organism | 9.443458e-6 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 9.510344e-6 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 9.809774e-6 |
GO:0006937 | regulation of muscle contraction | 1.009603e-5 |
GO:0000103 | sulfate assimilation | 1.044249e-5 |
GO:0000724 | double-strand break repair via homologous recombination | 1.151443e-5 |
GO:0006108 | malate metabolic process | 1.265383e-5 |
GO:0009617 | response to bacterium | 1.435492e-5 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 1.495825e-5 |
GO:0000725 | recombinational repair | 1.768439e-5 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 1.913666e-5 |
GO:0055119 | relaxation of cardiac muscle | 2.127223e-5 |
GO:0034754 | cellular hormone metabolic process | 2.180699e-5 |
GO:0042445 | hormone metabolic process | 2.233917e-5 |
GO:0010519 | negative regulation of phospholipase activity | 2.289268e-5 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 2.931994e-5 |
GO:0018960 | 4-nitrophenol metabolic process | 2.932268e-5 |
GO:0010574 | regulation of vascular endothelial growth factor production | 3.045458e-5 |
GO:0010661 | positive regulation of muscle cell apoptosis | 3.501416e-5 |
GO:0009635 | response to herbicide | 3.501416e-5 |
GO:0006787 | porphyrin-containing compound catabolic process | 3.618828e-5 |
GO:0001887 | selenium compound metabolic process | 3.618828e-5 |
GO:0090257 | regulation of muscle system process | 3.664499e-5 |
GO:0042472 | inner ear morphogenesis | 3.675694e-5 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.939187e-5 |
GO:0046600 | negative regulation of centriole replication | 4.179163e-5 |
GO:0009607 | response to biotic stimulus | 4.413145e-5 |
GO:0032496 | response to lipopolysaccharide | 4.469877e-5 |
GO:0002711 | positive regulation of T cell mediated immunity | 4.538283e-5 |
GO:0051187 | cofactor catabolic process | 4.564497e-5 |
GO:0031343 | positive regulation of cell killing | 4.584334e-5 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 4.973769e-5 |
GO:0002697 | regulation of immune effector process | 5.284037e-5 |
GO:0042471 | ear morphogenesis | 5.827423e-5 |
GO:0003008 | system process | 5.845176e-5 |
GO:0051135 | positive regulation of NK T cell activation | 5.905437e-5 |
GO:0090007 | regulation of mitotic anaphase | 6.452963e-5 |
GO:2000381 | negative regulation of mesoderm development | 7.149856e-5 |
GO:0031341 | regulation of cell killing | 7.334646e-5 |
GO:0006942 | regulation of striated muscle contraction | 8.237156e-5 |
GO:0048660 | regulation of smooth muscle cell proliferation | 8.855679e-5 |
GO:0043491 | protein kinase B signaling cascade | 8.876889e-5 |
GO:0002237 | response to molecule of bacterial origin | 9.958149e-5 |
GO:0061338 | atrioventricular node impulse conduction delay | 1.000411e-4 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.019816e-4 |
GO:0002437 | inflammatory response to antigenic stimulus | 1.039075e-4 |
GO:0070164 | negative regulation of adiponectin secretion | 1.145796e-4 |
GO:0042489 | negative regulation of odontogenesis of dentine-containing tooth | 1.145796e-4 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 1.145796e-4 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 1.160881e-4 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 1.185962e-4 |
GO:0007144 | female meiosis I | 1.262846e-4 |
GO:0048745 | smooth muscle tissue development | 1.314036e-4 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 1.353536e-4 |
GO:0030168 | platelet activation | 1.362473e-4 |
GO:0002703 | regulation of leukocyte mediated immunity | 1.364399e-4 |
GO:0042742 | defense response to bacterium | 1.395499e-4 |
GO:0031349 | positive regulation of defense response | 1.429420e-4 |
GO:0032425 | positive regulation of mismatch repair | 1.452482e-4 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.594613e-4 |
GO:2000191 | regulation of fatty acid transport | 1.749931e-4 |
GO:0046069 | cGMP catabolic process | 1.772395e-4 |
GO:0030593 | neutrophil chemotaxis | 1.805016e-4 |
GO:0051704 | multi-organism process | 1.823360e-4 |
GO:0002329 | pre-B cell differentiation | 1.848942e-4 |
GO:0010817 | regulation of hormone levels | 1.898943e-4 |
GO:0030178 | negative regulation of Wnt receptor signaling pathway | 1.915361e-4 |
GO:0046634 | regulation of alpha-beta T cell activation | 1.937164e-4 |
GO:0032700 | negative regulation of interleukin-17 production | 1.966546e-4 |
GO:0071436 | sodium ion export | 2.013135e-4 |
GO:0033152 | immunoglobulin V(D)J recombination | 2.021105e-4 |
GO:0046641 | positive regulation of alpha-beta T cell proliferation | 2.022984e-4 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 2.196086e-4 |
GO:0051984 | positive regulation of chromosome segregation | 2.253916e-4 |
GO:0032075 | positive regulation of nuclease activity | 2.363217e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 2.489322e-4 |
GO:0045907 | positive regulation of vasoconstriction | 2.493753e-4 |
GO:0032185 | septin cytoskeleton organization | 2.505642e-4 |
GO:0019370 | leukotriene biosynthetic process | 2.658636e-4 |
GO:0010963 | regulation of L-arginine import | 2.691725e-4 |
GO:0032892 | positive regulation of organic acid transport | 2.699496e-4 |
GO:0002426 | immunoglobulin production in mucosal tissue | 2.718542e-4 |
GO:0010517 | regulation of phospholipase activity | 2.819099e-4 |
GO:0046456 | icosanoid biosynthetic process | 2.828387e-4 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 2.949395e-4 |
GO:0007586 | digestion | 3.058104e-4 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 3.086424e-4 |
GO:0050796 | regulation of insulin secretion | 3.098651e-4 |
GO:0061337 | cardiac conduction | 3.277149e-4 |
GO:0042446 | hormone biosynthetic process | 3.542119e-4 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 3.545226e-4 |
GO:0007614 | short-term memory | 3.545226e-4 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 3.558758e-4 |
GO:0090276 | regulation of peptide hormone secretion | 3.664235e-4 |
GO:0021935 | cerebellar granule cell precursor tangential migration | 3.666509e-4 |
GO:0006104 | succinyl-CoA metabolic process | 3.666509e-4 |
GO:0051645 | Golgi localization | 3.693632e-4 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 3.698287e-4 |
GO:0031023 | microtubule organizing center organization | 3.763329e-4 |
GO:0055114 | oxidation-reduction process | 4.157818e-4 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 4.284444e-4 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 4.411179e-4 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 4.552604e-4 |
GO:0006749 | glutathione metabolic process | 4.709202e-4 |
GO:2000078 | positive regulation of type B pancreatic cell development | 4.725708e-4 |
GO:0051955 | regulation of amino acid transport | 4.778271e-4 |
GO:0006463 | steroid hormone receptor complex assembly | 4.919762e-4 |
GO:0080134 | regulation of response to stress | 5.068166e-4 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 5.166637e-4 |
GO:0071955 | recycling endosome to Golgi transport | 5.166637e-4 |
GO:0034499 | late endosome to Golgi transport | 5.166637e-4 |
GO:0031129 | inductive cell-cell signaling | 5.166637e-4 |
GO:0001736 | establishment of planar polarity | 5.180455e-4 |
GO:0045932 | negative regulation of muscle contraction | 5.215746e-4 |
GO:0006750 | glutathione biosynthetic process | 5.257440e-4 |
GO:0001879 | detection of yeast | 5.467799e-4 |
GO:0015721 | bile acid and bile salt transport | 5.538792e-4 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.713107e-4 |
GO:0044237 | cellular metabolic process | 5.955096e-4 |
GO:0055117 | regulation of cardiac muscle contraction | 6.138706e-4 |
GO:0043277 | apoptotic cell clearance | 6.158505e-4 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 6.450481e-4 |
GO:0019693 | ribose phosphate metabolic process | 6.632570e-4 |
GO:0032729 | positive regulation of interferon-gamma production | 7.380179e-4 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 7.820227e-4 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 8.129648e-4 |
GO:0002791 | regulation of peptide secretion | 8.345084e-4 |
GO:0016045 | detection of bacterium | 8.587652e-4 |
GO:0032872 | regulation of stress-activated MAPK cascade | 8.648059e-4 |
GO:0007164 | establishment of tissue polarity | 8.648059e-4 |
GO:0001672 | regulation of chromatin assembly or disassembly | 8.765866e-4 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 8.828576e-4 |
GO:0050996 | positive regulation of lipid catabolic process | 8.952103e-4 |
GO:0006952 | defense response | 8.989915e-4 |
GO:0033151 | V(D)J recombination | 9.004824e-4 |
GO:0051241 | negative regulation of multicellular organismal process | 9.010642e-4 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 9.348516e-4 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 9.348516e-4 |
GO:0047484 | regulation of response to osmotic stress | 9.388135e-4 |
GO:0006691 | leukotriene metabolic process | 9.390831e-4 |
GO:0006393 | termination of mitochondrial transcription | 9.511596e-4 |
GO:0045988 | negative regulation of striated muscle contraction | 1.018890e-3 |
GO:0061181 | regulation of chondrocyte development | 1.065444e-3 |
GO:0001556 | oocyte maturation | 1.086605e-3 |
GO:0010669 | epithelial structure maintenance | 1.103300e-3 |
GO:0048016 | inositol phosphate-mediated signaling | 1.131669e-3 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 1.159485e-3 |
GO:0032787 | monocarboxylic acid metabolic process | 1.161667e-3 |
GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter | 1.221261e-3 |
GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process | 1.221261e-3 |
GO:0002544 | chronic inflammatory response | 1.233262e-3 |
GO:0006940 | regulation of smooth muscle contraction | 1.246508e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 1.250657e-3 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 1.258471e-3 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 1.265882e-3 |
GO:0048839 | inner ear development | 1.277117e-3 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 1.278258e-3 |
GO:0002709 | regulation of T cell mediated immunity | 1.320924e-3 |
GO:0051179 | localization | 1.323490e-3 |
GO:0006288 | base-excision repair, DNA ligation | 1.337795e-3 |
GO:0006014 | D-ribose metabolic process | 1.354261e-3 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 1.416453e-3 |
GO:0090075 | relaxation of muscle | 1.419033e-3 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 1.444691e-3 |
GO:0060420 | regulation of heart growth | 1.498501e-3 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.512522e-3 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 1.512522e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.526619e-3 |
GO:0006082 | organic acid metabolic process | 1.533747e-3 |
GO:0055021 | regulation of cardiac muscle tissue growth | 1.540425e-3 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 1.558177e-3 |
GO:0014743 | regulation of muscle hypertrophy | 1.576016e-3 |
GO:0010863 | positive regulation of phospholipase C activity | 1.722618e-3 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.735045e-3 |
GO:0008154 | actin polymerization or depolymerization | 1.742374e-3 |
GO:0050896 | response to stimulus | 1.775518e-3 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.781569e-3 |
GO:0009125 | nucleoside monophosphate catabolic process | 1.787267e-3 |
GO:0033280 | response to vitamin D | 1.807734e-3 |
GO:0007202 | activation of phospholipase C activity | 1.843337e-3 |
GO:0006084 | acetyl-CoA metabolic process | 1.902698e-3 |
GO:0046339 | diacylglycerol metabolic process | 1.919427e-3 |
GO:0015701 | bicarbonate transport | 1.919427e-3 |
GO:0071477 | cellular hypotonic salinity response | 1.954682e-3 |
GO:0032308 | positive regulation of prostaglandin secretion | 1.964347e-3 |
GO:0046599 | regulation of centriole replication | 1.964347e-3 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 1.964347e-3 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 2.005663e-3 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 2.010003e-3 |
GO:0031929 | TOR signaling cascade | 2.010003e-3 |
GO:0006986 | response to unfolded protein | 2.029529e-3 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 2.032688e-3 |
GO:0007157 | heterophilic cell-cell adhesion | 2.033319e-3 |
GO:0021589 | cerebellum structural organization | 2.084048e-3 |
GO:0045947 | negative regulation of translational initiation | 2.124912e-3 |
GO:0070163 | regulation of adiponectin secretion | 2.141842e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 2.141842e-3 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 2.141842e-3 |
GO:0046851 | negative regulation of bone remodeling | 2.179363e-3 |
GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter | 2.190076e-3 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 2.215881e-3 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 2.233648e-3 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 2.363964e-3 |
GO:0002706 | regulation of lymphocyte mediated immunity | 2.366051e-3 |
GO:0001819 | positive regulation of cytokine production | 2.399174e-3 |
GO:0002639 | positive regulation of immunoglobulin production | 2.400735e-3 |
GO:0010501 | RNA secondary structure unwinding | 2.415827e-3 |
GO:0009204 | deoxyribonucleoside triphosphate catabolic process | 2.422310e-3 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 2.442690e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 2.442690e-3 |
GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 2.501205e-3 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 2.512934e-3 |
GO:0006690 | icosanoid metabolic process | 2.523251e-3 |
GO:0050729 | positive regulation of inflammatory response | 2.648355e-3 |
GO:0042180 | cellular ketone metabolic process | 2.677008e-3 |
GO:0019752 | carboxylic acid metabolic process | 2.678231e-3 |
GO:0032660 | regulation of interleukin-17 production | 2.782516e-3 |
GO:0033299 | secretion of lysosomal enzymes | 2.798718e-3 |
GO:0006310 | DNA recombination | 2.798898e-3 |
GO:0043583 | ear development | 2.799957e-3 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 2.836122e-3 |
GO:0006670 | sphingosine metabolic process | 2.859889e-3 |
GO:0043506 | regulation of JUN kinase activity | 2.870751e-3 |
GO:0000003 | reproduction | 2.891203e-3 |
GO:0042167 | heme catabolic process | 2.946560e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 2.949487e-3 |
GO:0001738 | morphogenesis of a polarized epithelium | 2.987559e-3 |
GO:0030901 | midbrain development | 3.015333e-3 |
GO:0006686 | sphingomyelin biosynthetic process | 3.047311e-3 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 3.057333e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 3.068947e-3 |
GO:0014054 | positive regulation of gamma-aminobutyric acid secretion | 3.116662e-3 |
GO:0002026 | regulation of the force of heart contraction | 3.128118e-3 |
GO:0006672 | ceramide metabolic process | 3.159441e-3 |
GO:0032069 | regulation of nuclease activity | 3.231213e-3 |
GO:0051094 | positive regulation of developmental process | 3.376769e-3 |
GO:0045860 | positive regulation of protein kinase activity | 3.382506e-3 |
GO:0046068 | cGMP metabolic process | 3.403980e-3 |
GO:0042832 | defense response to protozoan | 3.406029e-3 |
GO:0003416 | endochondral bone growth | 3.406029e-3 |
GO:0031581 | hemidesmosome assembly | 3.451459e-3 |
GO:0009214 | cyclic nucleotide catabolic process | 3.469559e-3 |
GO:0060662 | salivary gland cavitation | 3.470262e-3 |
GO:0007218 | neuropeptide signaling pathway | 3.481101e-3 |
GO:0003013 | circulatory system process | 3.521640e-3 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 3.533003e-3 |
GO:0050880 | regulation of blood vessel size | 3.545277e-3 |
GO:0060032 | notochord regression | 3.551712e-3 |
GO:0003018 | vascular process in circulatory system | 3.594666e-3 |
GO:0031347 | regulation of defense response | 3.614174e-3 |
GO:0042129 | regulation of T cell proliferation | 3.622377e-3 |
GO:0035150 | regulation of tube size | 3.627076e-3 |
GO:0001657 | ureteric bud development | 3.666441e-3 |
GO:0050882 | voluntary musculoskeletal movement | 3.675462e-3 |
GO:0032320 | positive regulation of Ras GTPase activity | 3.827390e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 3.852819e-3 |
GO:0033574 | response to testosterone stimulus | 3.859454e-3 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 3.912604e-3 |
GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 3.912604e-3 |
GO:0006099 | tricarboxylic acid cycle | 3.922363e-3 |
GO:0002676 | regulation of chronic inflammatory response | 4.021886e-3 |
GO:0009615 | response to virus | 4.038256e-3 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 4.101536e-3 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 4.151799e-3 |
GO:0001817 | regulation of cytokine production | 4.154925e-3 |
GO:0050702 | interleukin-1 beta secretion | 4.180530e-3 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 4.190467e-3 |
GO:0009268 | response to pH | 4.199965e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 4.265723e-3 |
GO:0051297 | centrosome organization | 4.296019e-3 |
GO:0034113 | heterotypic cell-cell adhesion | 4.375914e-3 |
GO:0031340 | positive regulation of vesicle fusion | 4.567787e-3 |
GO:0030098 | lymphocyte differentiation | 4.653361e-3 |
GO:0033674 | positive regulation of kinase activity | 4.727008e-3 |
GO:0030033 | microvillus assembly | 4.733200e-3 |
GO:0032611 | interleukin-1 beta production | 4.733200e-3 |
GO:0050794 | regulation of cellular process | 4.907788e-3 |
GO:0002837 | regulation of immune response to tumor cell | 4.928653e-3 |
GO:0010269 | response to selenium ion | 4.936731e-3 |
GO:0071472 | cellular response to salt stress | 5.003844e-3 |
GO:0001865 | NK T cell differentiation | 5.003844e-3 |
GO:0032633 | interleukin-4 production | 5.003844e-3 |
GO:0002821 | positive regulation of adaptive immune response | 5.006843e-3 |
GO:0042403 | thyroid hormone metabolic process | 5.082005e-3 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 5.188166e-3 |
GO:0055091 | phospholipid homeostasis | 5.292038e-3 |
GO:0035966 | response to topologically incorrect protein | 5.292417e-3 |
GO:0002637 | regulation of immunoglobulin production | 5.292417e-3 |
GO:0045830 | positive regulation of isotype switching | 5.299679e-3 |
GO:0014048 | regulation of glutamate secretion | 5.299679e-3 |
GO:0032793 | positive regulation of CREB transcription factor activity | 5.374657e-3 |
GO:0008152 | metabolic process | 5.413713e-3 |
GO:0045577 | regulation of B cell differentiation | 5.422904e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 5.475087e-3 |
GO:0019098 | reproductive behavior | 5.525349e-3 |
GO:0032649 | regulation of interferon-gamma production | 5.547644e-3 |
GO:0045454 | cell redox homeostasis | 5.582093e-3 |
GO:0016310 | phosphorylation | 5.684377e-3 |
GO:0008610 | lipid biosynthetic process | 5.727777e-3 |
GO:0043300 | regulation of leukocyte degranulation | 5.757519e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 5.815980e-3 |
GO:0010464 | regulation of mesenchymal cell proliferation | 5.852696e-3 |
GO:0051017 | actin filament bundle assembly | 5.853364e-3 |
GO:0016539 | intein-mediated protein splicing | 5.859690e-3 |
GO:0050877 | neurological system process | 5.861931e-3 |
GO:0016575 | histone deacetylation | 5.948448e-3 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 5.990616e-3 |
GO:0050830 | defense response to Gram-positive bacterium | 6.047359e-3 |
GO:0031399 | regulation of protein modification process | 6.135672e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.145151e-3 |
GO:0065008 | regulation of biological quality | 6.153505e-3 |
GO:0046519 | sphingoid metabolic process | 6.170739e-3 |
GO:0051983 | regulation of chromosome segregation | 6.194113e-3 |
GO:0031503 | protein complex localization | 6.349913e-3 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 6.349913e-3 |
GO:0001562 | response to protozoan | 6.415250e-3 |
GO:0023057 | negative regulation of signaling | 6.416088e-3 |
GO:0010518 | positive regulation of phospholipase activity | 6.436669e-3 |
GO:0006776 | vitamin A metabolic process | 6.503223e-3 |
GO:0022414 | reproductive process | 6.601799e-3 |
GO:0072560 | type B pancreatic cell maturation | 6.648758e-3 |
GO:0055024 | regulation of cardiac muscle tissue development | 6.696196e-3 |
GO:0015870 | acetylcholine transport | 6.699923e-3 |
GO:0042221 | response to chemical stimulus | 6.733623e-3 |
GO:0046356 | acetyl-CoA catabolic process | 6.768245e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 6.779079e-3 |
GO:0032370 | positive regulation of lipid transport | 6.786659e-3 |
GO:0006629 | lipid metabolic process | 6.792736e-3 |
GO:2000193 | positive regulation of fatty acid transport | 6.834391e-3 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 6.834391e-3 |
GO:0010648 | negative regulation of cell communication | 6.960536e-3 |
GO:0002456 | T cell mediated immunity | 6.982590e-3 |
GO:0006633 | fatty acid biosynthetic process | 7.105255e-3 |
GO:0034976 | response to endoplasmic reticulum stress | 7.177797e-3 |
GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 7.302731e-3 |
GO:0045410 | positive regulation of interleukin-6 biosynthetic process | 7.465942e-3 |
GO:0003341 | cilium movement | 7.465942e-3 |
GO:0032268 | regulation of cellular protein metabolic process | 7.486808e-3 |
GO:0046496 | nicotinamide nucleotide metabolic process | 7.514976e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 7.563117e-3 |
GO:0043507 | positive regulation of JUN kinase activity | 7.782592e-3 |
GO:2000384 | negative regulation of ectoderm development | 7.851698e-3 |
GO:0071639 | positive regulation of monocyte chemotactic protein-1 production | 7.851698e-3 |
GO:0090161 | Golgi ribbon formation | 7.851698e-3 |
GO:0042574 | retinal metabolic process | 7.855703e-3 |
GO:0006206 | pyrimidine base metabolic process | 7.907914e-3 |
GO:0090103 | cochlea morphogenesis | 7.915619e-3 |
GO:0002521 | leukocyte differentiation | 8.063260e-3 |
GO:0051239 | regulation of multicellular organismal process | 8.083678e-3 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 8.105145e-3 |
GO:0008347 | glial cell migration | 8.150987e-3 |
GO:0045088 | regulation of innate immune response | 8.157309e-3 |
GO:0015718 | monocarboxylic acid transport | 8.228115e-3 |
GO:0030423 | targeting of mRNA for destruction involved in RNA interference | 8.269599e-3 |
GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine | 8.269599e-3 |
GO:0043406 | positive regulation of MAP kinase activity | 8.312715e-3 |
GO:0051347 | positive regulation of transferase activity | 8.325977e-3 |
GO:0048562 | embryonic organ morphogenesis | 8.369840e-3 |
GO:0009109 | coenzyme catabolic process | 8.404999e-3 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 8.404999e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 8.424818e-3 |
GO:0032736 | positive regulation of interleukin-13 production | 8.438929e-3 |
GO:0043043 | peptide biosynthetic process | 8.464120e-3 |
GO:0050855 | regulation of B cell receptor signaling pathway | 8.465033e-3 |
GO:0007340 | acrosome reaction | 8.465033e-3 |
GO:0006821 | chloride transport | 8.815842e-3 |
GO:0045911 | positive regulation of DNA recombination | 8.873180e-3 |
GO:0045162 | clustering of voltage-gated sodium channels | 8.995544e-3 |
GO:0006704 | glucocorticoid biosynthetic process | 9.053342e-3 |
GO:0045779 | negative regulation of bone resorption | 9.053342e-3 |
GO:0033043 | regulation of organelle organization | 9.117378e-3 |
GO:0009595 | detection of biotic stimulus | 9.370091e-3 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 9.446261e-3 |
GO:0050852 | T cell receptor signaling pathway | 9.569353e-3 |
GO:0070327 | thyroid hormone transport | 9.577646e-3 |
GO:0045089 | positive regulation of innate immune response | 9.584161e-3 |
GO:0051054 | positive regulation of DNA metabolic process | 9.589910e-3 |
GO:0007417 | central nervous system development | 9.708856e-3 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 9.795300e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 9.967914e-3 |
GO:0032849 | positive regulation of cellular pH reduction | 1.012577e-2 |
GO:0060155 | platelet dense granule organization | 1.012577e-2 |
GO:0071476 | cellular hypotonic response | 1.024271e-2 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.037944e-2 |
GO:0002385 | mucosal immune response | 1.051095e-2 |
GO:0045597 | positive regulation of cell differentiation | 1.054158e-2 |
GO:0009060 | aerobic respiration | 1.056748e-2 |
GO:0006950 | response to stress | 1.066307e-2 |
GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 1.067767e-2 |
GO:0035725 | sodium ion transmembrane transport | 1.090094e-2 |
GO:0030217 | T cell differentiation | 1.105505e-2 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 1.113986e-2 |
GO:0015670 | carbon dioxide transport | 1.113986e-2 |
GO:0043366 | beta selection | 1.113986e-2 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 1.119399e-2 |
GO:0030041 | actin filament polymerization | 1.119399e-2 |
GO:0032506 | cytokinetic process | 1.120862e-2 |
GO:0042311 | vasodilation | 1.132918e-2 |
GO:0002839 | positive regulation of immune response to tumor cell | 1.133633e-2 |
GO:0019400 | alditol metabolic process | 1.146308e-2 |
GO:0001523 | retinoid metabolic process | 1.146308e-2 |
GO:2000383 | regulation of ectoderm development | 1.159650e-2 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 1.159650e-2 |
GO:0007418 | ventral midline development | 1.159650e-2 |
GO:0016476 | regulation of embryonic cell shape | 1.159650e-2 |
GO:0015698 | inorganic anion transport | 1.163306e-2 |
GO:0008016 | regulation of heart contraction | 1.164461e-2 |
GO:0051099 | positive regulation of binding | 1.185594e-2 |
GO:0048519 | negative regulation of biological process | 1.196810e-2 |
GO:0046883 | regulation of hormone secretion | 1.204461e-2 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1.215177e-2 |
GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 1.215177e-2 |
GO:0031953 | negative regulation of protein autophosphorylation | 1.215218e-2 |
GO:0050701 | interleukin-1 secretion | 1.222100e-2 |
GO:0045621 | positive regulation of lymphocyte differentiation | 1.225659e-2 |
GO:0034104 | negative regulation of tissue remodeling | 1.227356e-2 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 1.227356e-2 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 1.230172e-2 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 1.236509e-2 |
GO:0045668 | negative regulation of osteoblast differentiation | 1.237206e-2 |
GO:0045582 | positive regulation of T cell differentiation | 1.247832e-2 |
GO:0006417 | regulation of translation | 1.259469e-2 |
GO:0006081 | cellular aldehyde metabolic process | 1.261136e-2 |
GO:0042102 | positive regulation of T cell proliferation | 1.261452e-2 |
GO:0031342 | negative regulation of cell killing | 1.273850e-2 |
GO:0002251 | organ or tissue specific immune response | 1.290731e-2 |
GO:0046427 | positive regulation of JAK-STAT cascade | 1.297679e-2 |
GO:0090231 | regulation of spindle checkpoint | 1.302640e-2 |
GO:0009649 | entrainment of circadian clock | 1.302640e-2 |
GO:0002698 | negative regulation of immune effector process | 1.302828e-2 |
GO:0035802 | adrenal cortex formation | 1.305995e-2 |
GO:0019852 | L-ascorbic acid metabolic process | 1.306558e-2 |
GO:0070980 | biphenyl catabolic process | 1.313449e-2 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.326423e-2 |
GO:0046321 | positive regulation of fatty acid oxidation | 1.327734e-2 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 1.328441e-2 |
GO:0032612 | interleukin-1 production | 1.337104e-2 |
GO:0051052 | regulation of DNA metabolic process | 1.344409e-2 |
GO:0016578 | histone deubiquitination | 1.344623e-2 |
GO:0097113 | alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering | 1.344623e-2 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 1.356504e-2 |
GO:0046328 | regulation of JNK cascade | 1.360682e-2 |
GO:0060968 | regulation of gene silencing | 1.380512e-2 |
GO:0042572 | retinol metabolic process | 1.380512e-2 |
GO:0032609 | interferon-gamma production | 1.400847e-2 |
GO:0014052 | regulation of gamma-aminobutyric acid secretion | 1.400847e-2 |
GO:0002831 | regulation of response to biotic stimulus | 1.413792e-2 |
GO:0065007 | biological regulation | 1.423149e-2 |
GO:0042325 | regulation of phosphorylation | 1.423937e-2 |
GO:0031622 | positive regulation of fever generation | 1.430452e-2 |
GO:0034435 | cholesterol esterification | 1.430452e-2 |
GO:0010824 | regulation of centrosome duplication | 1.430452e-2 |
GO:0007605 | sensory perception of sound | 1.441098e-2 |
GO:0046186 | acetaldehyde biosynthetic process | 1.442182e-2 |
GO:0006788 | heme oxidation | 1.442182e-2 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 1.459180e-2 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 1.463590e-2 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 1.466034e-2 |
GO:0045921 | positive regulation of exocytosis | 1.471328e-2 |
GO:0046685 | response to arsenic-containing substance | 1.484475e-2 |
GO:0010224 | response to UV-B | 1.484475e-2 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 1.484475e-2 |
GO:0014850 | response to muscle activity | 1.484475e-2 |
GO:0043011 | myeloid dendritic cell differentiation | 1.484475e-2 |
GO:0002833 | positive regulation of response to biotic stimulus | 1.490563e-2 |
GO:0006208 | pyrimidine base catabolic process | 1.495442e-2 |
GO:0006098 | pentose-phosphate shunt | 1.502306e-2 |
GO:0009581 | detection of external stimulus | 1.510635e-2 |
GO:0006406 | mRNA export from nucleus | 1.511083e-2 |
GO:0090273 | regulation of somatostatin secretion | 1.520118e-2 |
GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 1.537496e-2 |
GO:0006766 | vitamin metabolic process | 1.550329e-2 |
GO:0006909 | phagocytosis | 1.566552e-2 |
GO:0006621 | protein retention in ER lumen | 1.612501e-2 |
GO:0043306 | positive regulation of mast cell degranulation | 1.613707e-2 |
GO:0006266 | DNA ligation | 1.613707e-2 |
GO:0042404 | thyroid hormone catabolic process | 1.620654e-2 |
GO:0050885 | neuromuscular process controlling balance | 1.624120e-2 |
GO:0085020 | protein K6-linked ubiquitination | 1.632692e-2 |
GO:0071637 | regulation of monocyte chemotactic protein-1 production | 1.632692e-2 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 1.632692e-2 |